TickerFacts.

SpyGlass Pharma, Inc. (SGP): Capital Expenditures

Annual figures by period end, from SEC filings.

$789.0K
Year ended 2025-12-31
$3.18M
Trailing 12 months to 2026-06-30
$1.99M2024-12-31: $1.99M2025-12-31: $789.0K$789.0K
2024-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$789.0K-60.4%2026-03-26, From 2025-01-01
2024-12-31$1.99Mn/a2026-03-26, From 2024-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
SpyGlass Pharma, Inc. (SGP)2025-12-31$789.0K-60.4%
Sight Sciences, Inc. (SGHT)2025-12-31$224.0K-41.8%
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$489.0K+69.2%
Fractyl Health, Inc. (GUTS)2025-12-31$557.0K-68.4%
DarioHealth Corp. (DRIO)2025-12-31$142.0K+2.9%
Utah Medical Products Inc (UTMD)2025-12-31$371.0K+61.3%
Iradimed Corp (IRMD)2025-12-31$7.76M-3.0%
Delcath Systems, Inc. (DCTH)2025-12-31$1.55M+176.7%
Alpha Tau Medical Ltd. (DRTS)2025-12-31$6.08M+171.4%

Compare SGP, SGHT, OBIO, GUTS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗